Research summary, narrative review, 2015

ACC - Radiation Safety for the Interventional Cardiologist

2015

Open the source page

In plain language

This review summarises cited evidence on brain tumor, cataract, thyroid, reproductive and orthopedic risks among cath lab staff, and recommends practical dose-reduction steps, personal and suspended shielding, protective caps, and robotic systems for interventional cardiologists and the fluoroscopy team.

At a glance

Type of study
Narrative review
Who was studied
Interventional cardiologists, Nurses, Radiologic technologists, Mixed lab staff
Summary based on
a web page

What it found

  • Cited data show left-sided predominance of brain tumors among physicians performing fluoroscopic interventions.

    Key figures: 22 of 26 cases (85%)

  • In a cited study of 11 cardiologists, left-side head exposure exceeded right side and was attenuated by a radiation protection cap.

    Key figures: 106.1 +/- 33.6 vs. 50.2 +/- 16.2 mrad, p < 0.001; with cap 42.3 +/- 3.5 mrad

  • Nearly half of active interventional operators report orthopedic injury, prompting the authors to recommend ceiling-suspended or floor-mounted personal shielding and call for Occupational Safety and Health Administration (OSHA) oversight.

    Key figures: 49%

  • Reducing fluoroscopy pulse rate lowers radiation exposure substantially.

    Key figures: 67%

  • A larger ceiling-mounted shield with lamellae plus drape halved operator exposure in a cited study.

    Key figures: decreased by half

Limits to keep in mind

Narrative review and editorial summarising cited studies without systematic methods; figures come from secondary citation rather than original data.

How this summary was made

ORSIF prepared this summary with AI assistance from a web page of the paper. A program then checked that the passage supporting each finding appears word for word in that source. A person has not yet reviewed each summary, so read the original before relying on a number. ORSIF summarizes research and does not endorse any product or company. Report a problem with this summary.

Prepared November 5, 2026.